{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:20:01Z","timestamp":1767140401907,"version":"build-2238731810"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-023-03711-7","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T02:02:40Z","timestamp":1674266560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic value of choroidal vascular index in determining response to intravitreal dexamethasone implant treatment used in refractory diabetic macular edema"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5003-3834","authenticated-orcid":false,"given":"Serdar","family":"\u0130lg\u00fcy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmed U\u011fur","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,21]]},"reference":[{"key":"3711_CR1","doi-asserted-by":"publisher","unstructured":"Bucolo C, Marrazzo G, Platania CB, Drago F, Leggio GM, Salomone S (2013) Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy. J Diabetes Res 2013:432695. https:\/\/doi.org\/10.1155\/2013\/432695","DOI":"10.1155\/2013\/432695"},{"issue":"7","key":"3711_CR2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.yexcr.2013.01.012","volume":"319","author":"TS Devi","year":"2013","unstructured":"Devi TS, Hosoya K, Terasaki T, Singh LP (2013) Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy. Exp Cell Res 319(7):1001\u20131012. https:\/\/doi.org\/10.1016\/j.yexcr.2013.01.012","journal-title":"Exp Cell Res"},{"key":"3711_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.visres.2017.04.011","volume":"139","author":"GA Lutty","year":"2017","unstructured":"Lutty GA (2017) Diabetic choroidopathy. Vision Res 139:161\u2013167. https:\/\/doi.org\/10.1016\/j.visres.2017.04.011","journal-title":"Vision Res"},{"issue":"4 Suppl","key":"3711_CR4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.3928\/23258160-20160224-01","volume":"47","author":"CA Puliafito","year":"2016","unstructured":"Puliafito CA, Cousins SW, Bacharach J, Gonzalez VH, Holekamp NM, Merrill PT et al (2016) Forming a consensus: data and guidance for physicians treating diabetic macular edema. Ophthalmic Surg Lasers Imaging Retina 47(4 Suppl):S4\u2013S15. https:\/\/doi.org\/10.3928\/23258160-20160224-01","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"3711_CR5","doi-asserted-by":"publisher","unstructured":"Bolinger MT, Antonetti DA (2016) Moving past Anti-VEGF: novel therapies for treating diabetic retinopathy. Int J Mol Sci 17(9). https:\/\/doi.org\/10.3390\/ijms17091498","DOI":"10.3390\/ijms17091498"},{"issue":"3","key":"3711_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/02713683.2020.1842463","volume":"46","author":"M Alisik","year":"2021","unstructured":"Alisik M, Isik MU (2021) The relationship between choroidal thickness and intracellular oxidised-reduced glutathione and extracellular thiol-disulfide homeostasis at different stages of diabetic retinopathy. Curr Eye Res 46(3):367\u2013372. https:\/\/doi.org\/10.1080\/02713683.2020.1842463","journal-title":"Curr Eye Res"},{"issue":"8","key":"3711_CR7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1248\/bpb.31.1541","volume":"31","author":"K Wang","year":"2008","unstructured":"Wang K, Wang Y, Gao L, Li X, Li M, Guo J (2008) Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression. Biol Pharm Bull 31(8):1541\u20131546. https:\/\/doi.org\/10.1248\/bpb.31.1541","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"3711_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1046\/j.0022-3042.2001.00740.x","volume":"80","author":"DA Antonetti","year":"2002","unstructured":"Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC Jr (2002) Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 80(4):667\u2013677. https:\/\/doi.org\/10.1046\/j.0022-3042.2001.00740.x","journal-title":"J Neurochem"},{"issue":"4","key":"3711_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","volume":"146","author":"RF Spaide","year":"2008","unstructured":"Spaide RF, Koizumi H, Pozzoni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146(4):496\u2013500. https:\/\/doi.org\/10.1016\/j.ajo.2008.05.032","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3711_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/aos.13210","volume":"95","author":"A Campos","year":"2017","unstructured":"Campos A, Campos EJ, Martins J, Ambrosio AF, Silva R (2017) Viewing the choroid: where we stand, challenges and contradictions in diabetic retinopathy and diabetic macular oedema. Acta Ophthalmol 95(5):446\u2013459. https:\/\/doi.org\/10.1111\/aos.13210","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"3711_CR11","first-page":"707","volume":"151","author":"GA Lutty","year":"1997","unstructured":"Lutty GA, Cao J, McLeod DS (1997) Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 151(3):707\u2013714","journal-title":"Am J Pathol"},{"key":"3711_CR12","doi-asserted-by":"publisher","unstructured":"Li L, Almansoob S, Zhang P, Zhou YD, Tan Y, Gao L (2019) Quantitative analysis of retinal and choroid capillary ischaemia using optical coherence tomography angiography in type 2 diabetes. Acta Ophthalmol 97(3):240-246.\u00a0https:\/\/doi.org\/10.1111\/aos.14076","DOI":"10.1111\/aos.14076"},{"issue":"8","key":"3711_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/bjo.2003.035345","volume":"88","author":"T Nagaoka","year":"2004","unstructured":"Nagaoka T, Kitaya N, Sugawara R, Yokota H, Mori F, Hikichi T et al (2004) Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol 88(8):1060\u20131063. https:\/\/doi.org\/10.1136\/bjo.2003.035345","journal-title":"Br J Ophthalmol"},{"key":"3711_CR14","doi-asserted-by":"publisher","unstructured":"Hamadneh T, Aftab S, Sherali N, Vetrivel Suresh R, Tsouklidis N, An M (2020) Choroidal changes in diabetic patients with different stages of diabetic retinopathy. Cureus 12(10):e10871. https:\/\/doi.org\/10.7759\/cureus.10871","DOI":"10.7759\/cureus.10871"},{"issue":"11","key":"3711_CR15","first-page":"3799","volume":"35","author":"DS McLeod","year":"1994","unstructured":"McLeod DS, Lutty GA (1994) High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci 35(11):3799\u20133811","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3711_CR16","doi-asserted-by":"publisher","unstructured":"Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY (2016) Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study. Sci Rep 6:21090.\u00a0https:\/\/doi.org\/10.1038\/srep21090","DOI":"10.1038\/srep21090"},{"issue":"1","key":"3711_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41598-017-18511-7","volume":"8","author":"M Kim","year":"2018","unstructured":"Kim M, Ha MJ, Choi SY, Park YH (2018) Choroidal vascularity index in type-2 diabetes analyzed by swept-source optical coherence tomography. Sci Rep 8(1):70. https:\/\/doi.org\/10.1038\/s41598-017-18511-7","journal-title":"Sci Rep"},{"key":"3711_CR18","doi-asserted-by":"publisher","unstructured":"Gupta C, Tan R, Mishra C, Khandelwal N, Raman R, Kim R et al (2018) Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema-a novel OCT based imaging biomarker. PLoS One 13(12):e0207435. https:\/\/doi.org\/10.1371\/journal.pone.0207435","DOI":"10.1371\/journal.pone.0207435"},{"key":"3711_CR19","doi-asserted-by":"publisher","unstructured":"Tan KA, Laude A, Yip V, Loo E, Wong EP, Agrawal R (2016) Choroidal vascularity index - a novel optical coherence tomography parameter for disease monitoring in diabetes mellitus? Acta Ophthalmol 94(7):e612-e616.\u00a0https:\/\/doi.org\/10.1111\/aos.13044","DOI":"10.1111\/aos.13044"},{"key":"3711_CR20","doi-asserted-by":"publisher","first-page":"42201","DOI":"10.1038\/srep42201","volume":"7","author":"JP Campbell","year":"2017","unstructured":"Campbell JP, Zhang M, Hwang TS, Bailey ST, Wilson DJ, Jia Y et al (2017) Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep 7:42201. https:\/\/doi.org\/10.1038\/srep42201","journal-title":"Sci Rep"},{"issue":"2","key":"3711_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/b:inte.0000031744.93778.60","volume":"25","author":"LS Schocket","year":"2004","unstructured":"Schocket LS, Brucker AJ, Niknam RM, Grunwald JE, DuPont J, Brucker AJ (2004) Foveolar choroidal hemodynamics in proliferative diabetic retinopathy. Int Ophthalmol 25(2):89\u201394. https:\/\/doi.org\/10.1023\/b:inte.0000031744.93778.60","journal-title":"Int Ophthalmol"},{"key":"3711_CR22","doi-asserted-by":"crossref","unstructured":"Lampeter ER, Kishimoto TK, Rothlein R, Mainolfi EA, Bertrams J, Kolb H et al (1992) Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. 41(12):1668-71","DOI":"10.2337\/diabetes.41.12.1668"},{"issue":"4","key":"3711_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000499540","volume":"62","author":"D Zur","year":"2019","unstructured":"Zur D, Iglicki M, Loewenstein A (2019) The role of steroids in the management of diabetic macular edema. Ophthalmic Res 62(4):231\u2013236. https:\/\/doi.org\/10.1159\/000499540","journal-title":"Ophthalmic Res"},{"issue":"6","key":"3711_CR24","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1167\/iovs.14-14188","volume":"55","author":"S Sonoda","year":"2014","unstructured":"Sonoda S, Sakamoto T, Yamashita T, Otsuka H, Shirasawa M, Kakiuchi N et al (2014) Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 55(6):3979\u20133985. https:\/\/doi.org\/10.1167\/iovs.14-14188","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"3711_CR25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/IAE.0000000000003029","volume":"41","author":"KY Moon","year":"2021","unstructured":"Moon KY, Choi SY, Song JH (2021) Changes in subfoveal choroidal thickness after intravitreal dexamethasone implant therapy for diabetic macular edema. Retina 41(6):1283\u20131292. https:\/\/doi.org\/10.1097\/IAE.0000000000003029","journal-title":"Retina"},{"issue":"5","key":"3711_CR26","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/eye.2016.23","volume":"30","author":"M Kim","year":"2016","unstructured":"Kim M, Cho YJ, Lee CH, Lee SC (2016) Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections. Eye (Lond) 30(5):718\u2013725. https:\/\/doi.org\/10.1038\/eye.2016.23","journal-title":"Eye (Lond)"},{"issue":"5","key":"3711_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/IAE.0b013e318206d18c","volume":"31","author":"DS Boyer","year":"2011","unstructured":"Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY et al (2011) Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 31(5):915\u2013923. https:\/\/doi.org\/10.1097\/IAE.0b013e318206d18c","journal-title":"Retina"},{"issue":"1","key":"3711_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ophtha.2012.07.048","volume":"120","author":"WB Wei","year":"2013","unstructured":"Wei WB, Xu L, Jonas JB, Shao L, Du KF, Wang S et al (2013) Subfoveal choroidal thickness: the Beijing Eye Study. Ophthalmology 120(1):175\u2013180. https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.048","journal-title":"Ophthalmology"},{"issue":"1","key":"3711_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12886-019-1189-8","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang H, Tao Y (2019) Choroidal structural changes correlate with severity of diabetic retinopathy in diabetes mellitus. BMC Ophthalmol 19(1):186. https:\/\/doi.org\/10.1186\/s12886-019-1189-8","journal-title":"BMC Ophthalmol"},{"key":"3711_CR30","doi-asserted-by":"publisher","unstructured":"Foo VHX, Gupta P, Nguyen QD, Chong CCY, Agrawal R, Cheng CY et al (2020) Decrease in choroidal vascularity index of Haller\u2019s layer in diabetic eyes precedes retinopathy. BMJ Open Diabetes Res Care 8(1). https:\/\/doi.org\/10.1136\/bmjdrc-2020-001295","DOI":"10.1136\/bmjdrc-2020-001295"},{"key":"3711_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajo.2017.09.030","volume":"184","author":"JC Wang","year":"2017","unstructured":"Wang JC, Lains I, Providencia J, Armstrong GW, Santos AR, Gil P et al (2017) Diabetic choroidopathy: choroidal vascular density and volume in diabetic retinopathy with swept-source optical coherence tomography. Am J Ophthalmol 184:75\u201383. https:\/\/doi.org\/10.1016\/j.ajo.2017.09.030","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3711_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.exer.2004.09.013","volume":"80","author":"JL Edelman","year":"2005","unstructured":"Edelman JL, Lutz D, Castro MR (2005) Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 80(2):249\u2013258. https:\/\/doi.org\/10.1016\/j.exer.2004.09.013","journal-title":"Exp Eye Res"},{"key":"3711_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2147\/OPTH.S59395","volume":"8","author":"E Unsal","year":"2014","unstructured":"Unsal E, Eltutar K, Zirtiloglu S, Dincer N, Ozdogan Erkul S, Gungel H (2014) Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol 8:637\u2013642. https:\/\/doi.org\/10.2147\/OPTH.S59395","journal-title":"Clin Ophthalmol"},{"key":"3711_CR34","unstructured":"(2014) Ozurdex (dexamethasone intravitreal implant)[package insert]. Allergan, Inc, Irvine, CA. Available at: http:\/\/www.allergan.com\/assets\/pdf\/ozurdex_pi.pdf. Accessed October 6, 2014"},{"issue":"1","key":"3711_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1167\/iovs.10-5285","volume":"52","author":"JE Chang-Lin","year":"2011","unstructured":"Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD et al (2011) Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 52(1):80\u201386. https:\/\/doi.org\/10.1167\/iovs.10-5285","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3711_CR36","doi-asserted-by":"publisher","unstructured":"Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C et al (2007) Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol (Chicago, Ill : 1960) 125(3):309\u20131. https:\/\/doi.org\/10.1001\/archopht.125.3.309","DOI":"10.1001\/archopht.125.3.309"},{"issue":"2\u20133","key":"3711_CR37","first-page":"33","volume":"6","author":"R Urso","year":"2002","unstructured":"Urso R, Blardi P, Giorgi G (2002) A short introduction to pharmacokinetics. Eur Rev Med Pharmacol Sci 6(2\u20133):33\u201344","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"3711_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/ojo.ojo_7_21","volume":"14","author":"P Rishi","year":"2021","unstructured":"Rishi P, Verma A, Akhtar Z, Agrawal R, Agrawal A, Kalluri Bharat RP et al (2021) Intravitreal Ozurdex has no short term influence on choroidal thickness and vascularity index in eyes with diabetic macular edema: a pilot study. Oman J Ophthalmol 14(3):179\u2013183. https:\/\/doi.org\/10.4103\/ojo.ojo_7_21","journal-title":"Oman J Ophthalmol"},{"key":"3711_CR39","doi-asserted-by":"publisher","first-page":"6882607","DOI":"10.1155\/2022\/6882607","volume":"2022","author":"B Liu","year":"2022","unstructured":"Liu B, Ma G, Hou J, Cong C (2022) Choroidal structural changes of posterior subtenon triamcinolone acetonide injection in eyes with refractory diabetic macular edema. J Ophthalmol 2022:6882607. https:\/\/doi.org\/10.1155\/2022\/6882607","journal-title":"J Ophthalmol"},{"key":"3711_CR40","doi-asserted-by":"publisher","first-page":"3033219","DOI":"10.1155\/2021\/3033219","volume":"2021","author":"N Dou","year":"2021","unstructured":"Dou N, Yu S, Tsui CK, Yang B, Lin J, Lu X et al (2021) Choroidal vascularity index as a biomarker for visual response to antivascular endothelial growth factor treatment in diabetic macular edema. J Diabetes Res 2021:3033219. https:\/\/doi.org\/10.1155\/2021\/3033219","journal-title":"J Diabetes Res"}],"updated-by":[{"DOI":"10.1007\/s10103-023-03729-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000}}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-023-03711-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-023-03711-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-023-03711-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:52:23Z","timestamp":1703206343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-023-03711-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3711"],"URL":"https:\/\/doi.org\/10.1007\/s10103-023-03711-7","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,21]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10103-023-03729-x","URL":"https:\/\/doi.org\/10.1007\/s10103-023-03729-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were in accordance with the ethical standards of our institution\u2019s research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individuals included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"47"}}